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Abstract 
Epileptic diseases affect about 50 million people in the 
world and approximately 30% of patients diagnosed with 
epilepsy are unresponsive to current medications. For these 
reasons, primary prevention of epilepsy represents one of 
the priorities in epilepsy research. 
Intracellular oxido-reductive (redox) state is well 
known to play a crucial role, contributing to the 
maintenance of the proper function of biomolecules. 
Therefore, oxidative stress results in functional cellular 
disruption and cellular damage and may cause subsequent 
cell death via oxidation of proteins, lipids, and nucleotides. 
Recently, the role of oxidative stress in the early stage 
and in the progression of epileptic disorders has begun to 
be recognized. The early molecular response to oxidative 
stress represents a short-term reversible phenomenon that 
precedes higher and irreversible forms of oxidation. 
This article reviews the current understanding of the 
epileptogenic phenomena related to seizure-induced 
oxidative injury as potential “critical period” therapeutic 
targets for the prevention of chronic epileptic disorder. 
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Introduction 
Epilepsy is a disorder characterized by chronically 
recurring seizures and it represents the most frequent 
neurodegenerative disease after stroke. Epileptic 
disorders, in general, afflict more than 50 million 
people worldwide, affecting patients’ cognitive 
function, increasing risk of psychiatric disorders and 
mortality. Given its invalidating nature with a strong 
social impact, epileptic diseases economically 
contribute 0.5% of the global burden of disease.  
 
At present, the conventional antiepileptic drugs 
(AEDs) show partial or no efficacy in the treatment of 
some forms of refractory epilepsy such as Temporal 
Lobe Epilepsy (TLE). Furthermore, generally, AEDs 
can have important and irreversible side effects that 
can severely affect the patient’s quality of life, even 
more so in children, in which exposure to powerful 
anticonvulsant medications will have irreversible 
consequences on cognitive development.1 Given the 
invalidating nature of refractory forms of epilepsy, the 
need for novel effective treatments is undeniable. 
 
Epilepsy prevention approaches rest upon 
identification. Understanding of the underlying 
mechanisms of epilepsy development, and intervention 
targeted at these mechanisms in an appropriate time 
period after acute seizure could represent an important 
tool for novel therapeutic approaches aimed at 
preventing chronic irreversible epileptic disorder.  
 
Brain injury resulting from seizures is a dynamic 
process that comprises multiple factors contributing to 
a hyper-excitable state and neuronal reorganization 
underlying the chronic epileptic phenotype. In some 
forms of refractory epileptic disorders, such as TLE, 
the focus of seizure activity typically involves the 
hippocampal formation, which may develop 
pathological lesions, including neuronal loss and 
aberrant mossy fiber sprouting.2 
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Reactive Oxygen Species are generated during normal 
cellular metabolism3 and continuously scavenged by 
enzymatic and non-enzymatic antioxidant defense systems. 
However, excessive ROS levels due to increased ROS 
production and/or decreased antioxidant defense ability, 
leads to oxidative stress. 
 
Oxidative stress results in functional cellular 
disruption and cellular damage and may cause subsequent 
cell death via oxidation of biomolecules such as proteins, 
lipids, and nucleotides.  
 
The brain is particularly prone to oxidative stress 
because it utilizes a high amount of oxygen. Furthermore, 
the high concentrations of polyunsaturated fatty acids, that 
are prone to peroxidation, and metals, such as iron, which 
can catalyze hydroxyl radical formation, increase the brain 
susceptibility to oxidative stress. Therefore, oxidative 
injury in brain is one of the main causes of a number of 
neurologic conditions and neurodegenerative disorders, 
including Alzheimer’s disease, Parkinson’s disease, 
amyotrophic lateral sclerosis, and epilepsy,4 in which 
glutamatergic paroxysm-induced mitochondrial 
dysfunction and oxidative stress are among the crucial 
epileptogenic factors.  
 
Under physiological conditions, NMDARs are 
involved in long-term responses and neural plasticity in the 
brain. Via Ca2+ influx, NMDARs also modulate 
intracellular oxidant systems,5,6 including NADPH oxidase 
(NOX), which is a major source of superoxide production 
downstream the NMDAR activation. Changes in redox 
status participate in normal long-term neuronal responses 7 
and also regulate NMDAR channel function.8 However, 
oxidative stress can also promote altered function of 
neuronal cells when NMDAR activation is sustained.9  
 
Recent studies reported that the NADPH oxidase 
complex plays a crucial role in seizure-mediated 
superoxide production, in neuronal death in the pilocarpine 
model of epilepsy and in NMDAR subunits expression.10 
 
In particular, NR2B subunit is predominantly 
contained in pre-synaptic autoreceptors that tonically 
facilitate the glutamate release at excitatory synapses.11,12 
Moreover, recent studies have shown that NR2B is 
coupled with extracellular signal-regulated kinase 1/2 
(ERK1/2) signaling, whereas NR2A subunit is related to 
BDNF expression,13 a crucial factor in limbic 
epileptogenesis and in chronic TLE.14 
 
In this article, we focus on the emerging experimental 
evidences on oxidative stress as contributing factor in 
epileptogenesis by means the NMDARs’ subunits altered 
expression.  
 
Prevention of epilepsy in human subjects has been 
largely unsuccessful to this point. Understanding of 
the underlying oxidative stress-related mechanisms of 
epilepsy development, and intervention targeted at 
these mechanisms in an appropriate time period, could 
represent a successful strategy for the prevention of 
chronic epileptic disorders. 
 
Oxidative stress and NMDARs’ subunits expression 
NMDARs containing NR2A or NR2B subunits 
differ in kinetic properties, sensitivity to various 
ligands, permeability to divalent ions, and interactions 
with intracellular proteins.15 In the hippocampal area, 
AMPA and NMDA receptor subunit mRNA levels 
change dynamically during development, and in 
models of epilepsy, as animals progress from the latent 
to the chronic limbic seizure phase. These early 
stoichiometric changes in subunit composition may 
underlie plastic structural changes, such as aberrant 
mossy fiber sprouting, and cause an 
excitation/inhibition imbalance in neural networks that 
results in epileptogenesis.16,17 Therefore, 
understanding the molecular mechanisms accounting 
for these changes in NMDAR subunit composition 
could be is of critical importance to developing 
therapeutic interventions. 
 
In vitro and in vivo studies applying the 
pilocarpine (PILO) model of TLE, provided direct 
evidence that short-term exposure to PILO induces 
early over-expression of functional NR2B subunits in 
hippocampal neuronal cultures and in rat hippocampus 
by means of cooperative interaction between (i) 
NMDAR-enhanced NADPH oxidase activity with a 
resultant superoxide production and (ii) ERK1/2 
phosphorylation which is activated independently by 
m1R-mediated IP3 synthesis accompanied by 
increased expression of NR2B subunits.10  
 
NADPH oxidase is a cytoplasmic enzyme 
identified in many cell types (including neurons) that 
transfers an electron from NADPH to molecular 
oxygen to generate superoxide. Recent studies have 
suggested a mechanism by which Ca2+ influx through 
NMDAR channels leads to production of superoxide, 
and have described NADPH oxidase as the primary 
source of NMDA-induced superoxide production in 
neurons and a potential target to influence NMDAR-
mediated excitotoxicity in different models of epilepsy 
in rat.  
 
With respect to oxidative stress, thiol residues 
constitute some of the most important redox-sensitive 
functional groups of proteins and play a critical 
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regulatory role in numerous functions, including protein 
import, modulation of enzymatic signal transduction 
cascades, regulation of transcription factors and in the 
mitochondrial electron transport system.  
 
Evaluating the role of disulfide formation as critical 
molecular switch during the early response to PILO in 
relation to altered expression of NMDARs subunits, our 
findings suggest that the activation of NADPH oxidase 
constitutes the major biochemical link between the 
NMDA–Ca2+ transduction pathway and redox-sensitive 
regulatory transcription factors leading to the NR2B 
subunit over-expression after PILO exposure.  
Furthermore, the direct NMDAR activation in 
hippocampal neurons mediated by the exposure to free-
Mg2+ medium, elicits a NMDAR-Ca2+-dependent increase 
in thiol oxidation but no changes in NMDAR subunits 
expression were detected, suggesting that, in the PILO 
model, the NMDA–Ca2+-NADPH oxidase pathway 
represents only one arm of a more complex pathway, 
which leads to early induction of NR2B over expression.  
 
Substantial progress has been made in our 
understanding of how PILO causes long-term 
physiological changes in neurons. Previous work showed 
that m1R signaling leads to increased IP3 production in 
hippocampal neurons without a concurrent intracellular 
Ca2+ release.18 Our studies show that m1R-mediated IP3 
synthesis, constitutes the biochemical signal leading to 
NMDAR activation, thiol oxidation and NR2B subunit 
over-expression.  
 
Extracellular signal-regulated kinases 1 and 2 
(ERK1/2) are essential components of pathways through 
which signals received at membrane receptors are 
transduced to specific changes in protein function and gene 
expression. Extracellular stimuli such as neurotransmitters, 
neurotrophins and growth factors in the brain regulate 
critical cellular events, including synaptic transmission, 
neuronal plasticity, morphological differentiation and 
survival. ERK1/2 are abundantly expressed in the central 
nervous system and are activated in response to various 
physiological stimuli associated with synaptic activity and 
plasticity, but are also activated during pathological events 
such as brain ischemia and epilepsy. The present findings 
show that IP3-mediated ERK1/2 phosphorylation is a 
redox-independent pathway necessary, but not sufficient, 
for NR2B subunit over-expression. Therefore, the authors 
suggest that the early m1R-enhanced IP3 synthesis plays a 
crucial role by activating two different biochemical 
pathways: Ca2+-dependent oxidation (via NMDARs) and 
ERK1/2 activation. Both pathways are required for NR2A 
up-regulation. 
 
 
Oxidative stress and NMDARs function 
The cysteine residues on NMDARs are targets for 
S-nitrosylation and disulfide bond formation, 
implicating a critical role for reactive oxygen and 
nitrogen species in modulating NMDAR function.8 
Our results suggest that oxidation of thiols contained 
in NMDARs plays a potentially protective – but 
ultimately ineffective – role in preventing NMDAR-
mediated Ca2+ dysregulation after PILO treatment. 
Interestingly, NMDAR activation is a requisite 
proximal step that leads to oxidative stress, which, in 
turn, modulates NMDAR function. Taken together, 
these findings provide evidence that NMDAR-
mediated oxidative stress contributes in complex ways 
to epileptogenesis by playing an essential role in the 
upregulation of NR2B, and by directly modulating the 
site-specific entry of Ca2+ through NMDA channels, an 
important signal for initiating the cascade of molecular 
events that may contribute to delayed neuronal cell 
death in the context of epilepsy. 
 
 
 
Figure 1. Schematic diagram of PILO-induced changes in 
NMDARs.  
(1) PILO activation of m1R causes IP3 production, which 
in turn, independently activates ERK1/2 (2) and increases 
activation of NMDARs (3). Enhanced influx of Ca2+ 
through NMDARs (4) leads to activation of NOX (5) and 
generation of superoxide. This results in oxidative 
modification of cell surface NMDARs with impairment of 
receptor function (6). Additionally, the NOX-dependent 
oxidative stress together with ERK1/2 activation leads to 
upregulation of NR2B and NR1 subunits. 
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Conclusions 
In summary, this study provides evidence in the PILO 
model of TLE that muscarinic mR1-mediated stimulation 
of IP3 synthesis is a pivotal biochemical event for 
activating two independent pathways, which together, are 
critical for aberrant NMDAR subunit expression: Ca2+-
dependent NADPH oxidase activation and ERK1/2 
phosphorylation (Fig 1). Importantly, these are early 
biochemical phenomena that are required to induce NR2B 
over-expression. Early up-regulation of NR2B subunit 
may be involved in the induction and maintenance of 
epileptogenesis, since NR1/NR2B heterodimers are 
primarily expressed as facilitatory presynaptic 
autoreceptors on hippocampal neurons. In conclusion, 
these finding provide mechanistic insights into the 
biochemical phenomena underlying the oxidative response 
to an epileptogenic stimulus, and may inform development 
of new therapeutic approaches for chronic epileptic 
disorders prevention.  
 
References 
1. Mandelbaum DE, Burack GD, Bhise VV. Impact of antiepileptic 
drugs on cognition, behavior, and motor skills in children with 
new-onset, idiopathic epilepsy. Epilepsy Behav. 2009 
Oct;16(2):341-4. 
2. Mathern GW, Kuhlman PA, Mendoza D, Pretorius JK. Human 
fascia dentata anatomy and hippocampal neuron densities differ 
depending on the epileptic syndrome and age at first seizure. J 
Neuropathol Exp Neurol. 1997 Feb;56(2):199-212. 
3. Beit-Yannai E, Kohen R, Horowitz M, Trembovler V, Shohami E. 
Changes of biological reducing activity in rat brain following 
closed head injury: a cyclic voltammetry study in normal and heat-
acclimated rats. J Cereb Blood Flow Metab. 1997 Mar;17(3):273-9. 
4. Ashrafi MR, Shabanian R, Abbaskhanian A, Nasirian A, Ghofrani 
M, Mohammadi M, et al. Selenium and intractable epilepsy: is 
there any correlation? Pediatr Neurol. 2007 Jan;36(1):25-9 
5. Lafon-Cazal M, Pietri S, Culcasi M, Bockaert J. NMDA-dependent 
superoxide production and neurotoxicity. Nature. 1993 Aug 
5;364(6437):535-7. 
6. MacDermott AB, Mayer ML, Westbrook GL, Smith SJ, Barker JL. 
NMDA-receptor activation increases cytoplasmic calcium 
concentration in cultured spinal cord neurones. Nature. 1986 
May 29-Jun 4;321(6069):519-22. 
7. Klann E, Roberson ED, Knapp LT, Sweatt JD. A role for 
superoxide in protein kinase C activation and induction of 
long-term potentiation. J Biol Chem. 1998 Feb 
20;273(8):4516-22. 
8. Aizenman E, Hartnett KA, Reynolds IJ. Oxygen free radicals 
regulate NMDA receptor function via a redox modulatory site. 
Neuron. 1990 Dec;5(6):841-6. 
9. Patel H, Di Pietro E, Mejia N, MacKenzie RE. NAD- and 
NADP-dependent mitochondrially targeted 
methylenetetrahydrofolate dehydrogenase-cyclohydrolases 
can rescue mthfd2 null fibroblasts. Arch Biochem Biophys. 
2005 Oct 1;442(1):133-9. 
10. Di Maio R, Mastroberardino PG, Hu X, Montero L, 
Greenamyre JT. Pilocapine alters NMDA receptor expression 
and function in hippocampal neurons: NADPH oxidase and 
ERK1/2 mechanisms. Neurobiol Dis.  Jun;42(3):482-95. 
11. Berretta N, Jones RS. Tonic facilitation of glutamate release 
by presynaptic N-methyl-D-aspartate autoreceptors in the 
entorhinal cortex. Neuroscience. 1996 Nov;75(2):339-44. 
12. Woodhall G, Evans DI, Cunningham MO, Jones RS. NR2B-
containing NMDA autoreceptors at synapses on entorhinal 
cortical neurons. J Neurophysiol. 2001 Oct;86(4):1644-51. 
13. Chen Q, He S, Hu XL, Yu J, Zhou Y, Zheng J, et al. 
Differential roles of NR2A- and NR2B-containing NMDA 
receptors in activity-dependent brain-derived neurotrophic 
factor gene regulation and limbic epileptogenesis. J Neurosci. 
2007 Jan 17;27(3):542-52. 
14. Danzer SC, He X, McNamara JO. Ontogeny of seizure-
induced increases in BDNF immunoreactivity and TrkB 
receptor activation in rat hippocampus. Hippocampus. 
2004;14(3):345-55. 
15. Cull-Candy S, Brickley S, Farrant M. NMDA receptor 
subunits: diversity, development and disease. Curr Opin 
Neurobiol. 2001 Jun;11(3):327-35. 
16. Zagulska-Szymczak S, Filipkowski RK, Kaczmarek L. 
Kainate-induced genes in the hippocampus: lessons from 
expression patterns. Neurochem Int. 2001 May;38(6):485-501. 
17. Lukasiuk K, Kontula L, Pitkanen A. cDNA profiling of 
epileptogenesis in the rat brain. Eur J Neurosci. 2003 
Jan;17(2):271-9. 
18. Nash MS, Willets JM, Billups B, John Challiss RA, Nahorski 
SR. Synaptic activity augments muscarinic acetylcholine 
receptor-stimulated inositol 1,4,5-trisphosphate production to 
facilitate Ca2+ release in hippocampal neurons. J Biol Chem. 
2004 Nov 19;279(47):49036-44. 
    
 
 
 
 
 
 
